{"id":257,"date":"2020-04-08T09:20:06","date_gmt":"2020-04-08T09:20:06","guid":{"rendered":"https:\/\/apexbtic.icgeb.res.in\/btisnet\/?page_id=257"},"modified":"2021-01-29T09:45:45","modified_gmt":"2021-01-29T09:45:45","slug":"publications","status":"publish","type":"page","link":"https:\/\/apexbtic.icgeb.res.in\/btisnet\/publications\/","title":{"rendered":"Publications"},"content":{"rendered":"

<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Title<\/th>\nSource<\/th>\n<\/tr>\n
Lessons for COVID-19 Immunity from Other Coronavirus Infections<\/a><\/td>\nScienceDirect<\/span><\/td>\n<\/tr>\n
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma<\/a><\/td>\nScienceDirect<\/span><\/td>\n<\/tr>\n
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial <\/a><\/td>\nScienceDirect<\/span><\/td>\n<\/tr>\n
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection<\/a><\/td>\nAmerican Society of Hematology<\/span><\/td>\n<\/tr>\n
Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study<\/a><\/td>\nScienceDirect<\/span><\/td>\n<\/tr>\n
Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test <\/a><\/td>\nWiley Online Library<\/span><\/td>\n<\/tr>\n
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial <\/a><\/td>\nJama Network<\/span><\/td>\n<\/tr>\n
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 <\/a><\/td>\nThe New England Journal of Medicine<\/span><\/td>\n<\/tr>\n
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial <\/a><\/td>\nJama Network<\/span><\/td>\n<\/tr>\n
Serological differentiation between COVID-19 and SARS infections<\/a><\/td>\nTaylor & Francis Online<\/span><\/td>\n<\/tr>\n
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study <\/a><\/td>\nScienceDirect<\/span><\/td>\n<\/tr>\n
Kinetics of viral load and antibody response in relation to COVID-19 severity<\/a><\/td>\nThe Journal of Clinical Investigation<\/span><\/td>\n<\/tr>\n
Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID-19 <\/a><\/td>\nASCPT<\/span><\/td>\n<\/tr>\n
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial<\/a><\/td>\nBMJ Journals<\/span><\/td>\n<\/tr>\n
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial<\/a><\/td>\nScienceDirect<\/span><\/td>\n<\/tr>\n
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial <\/a><\/td>\nScienceDirect<\/span><\/td>\n<\/tr>\n
SMulti-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19<\/a><\/td>\nScienceDirect<\/span><\/td>\n<\/tr>\n
An mRNA Vaccine against SARS-CoV-2 – Preliminary Report <\/a><\/td>\nThe New England Journal of Medicine<\/span><\/td>\n<\/tr>\n
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial<\/a><\/td>\nScienceDirect<\/span><\/td>\n<\/tr>\n
Scent dog identification of samples from COVID-19 patients – a pilot study<\/a><\/td>\nBMC Infectious Diseases<\/span><\/td>\n<\/tr>\n
Phylogenomic analysis of SARS-CoV-2 genomes from western India reveals unique linked mutations<\/a><\/td>\nbiorxiv<\/span><\/td>\n<\/tr>\n
Identification of bioactive molecules from Tea plant as SARS-CoV-2 main protease inhibitors<\/a><\/td>\nTaylor & Francis Online<\/span><\/td>\n<\/tr>\n
Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals<\/a><\/td>\nCell<\/span><\/td>\n<\/tr>\n
What did we learn from the novel coronavirus genomes from India ?<\/a><\/td>\nGenomeconnect<\/span><\/td>\n<\/tr>\n
Infection of dogs with SARS-CoV-2<\/a><\/td>\nnature<\/span><\/td>\n<\/tr>\n
Dogs caught coronavirus from their owners, genetic analysis suggests<\/a><\/td>\nnature<\/span><\/td>\n<\/tr>\n
Dozens of coronavirus drugs are in development \u2014 what happens next?<\/a><\/td>\nnature<\/span><\/td>\n<\/tr>\n
Coronavirus in charts: are virtual conferences here to stay?<\/a><\/td>\nnature<\/span><\/td>\n<\/tr>\n
An interpretable mortality prediction model for COVID-19 patients<\/a><\/td>\nnature<\/span><\/td>\n<\/tr>\n
Real-time tracking of self-reported symptoms to predict potential COVID-19<\/a><\/td>\nnature<\/span><\/td>\n<\/tr>\n
Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis<\/a><\/td>\nbiorxiv<\/span><\/td>\n<\/tr>\n
Research Articles on COVID-19<\/a><\/td>\nGoogle Scholar<\/span><\/td>\n<\/tr>\n
Publications<\/a><\/td>\nCentres for Disease Control & Prevention<\/span><\/td>\n<\/tr>\n
COVID-19: a new challenge for human beings<\/a><\/td>\nnature<\/span><\/td>\n<\/tr>\n
An interactive web-based dashboard to track COVID-19 in real time<\/a><\/td>\nThe Lancet<\/span><\/td>\n<\/tr>\n
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations<\/a><\/td>\nThe Lancet<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Title Source Lessons for COVID-19 Immunity from Other Coronavirus Infections ScienceDirect Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}}},"_links":{"self":[{"href":"https:\/\/apexbtic.icgeb.res.in\/btisnet\/wp-json\/wp\/v2\/pages\/257"}],"collection":[{"href":"https:\/\/apexbtic.icgeb.res.in\/btisnet\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/apexbtic.icgeb.res.in\/btisnet\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/apexbtic.icgeb.res.in\/btisnet\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/apexbtic.icgeb.res.in\/btisnet\/wp-json\/wp\/v2\/comments?post=257"}],"version-history":[{"count":29,"href":"https:\/\/apexbtic.icgeb.res.in\/btisnet\/wp-json\/wp\/v2\/pages\/257\/revisions"}],"predecessor-version":[{"id":1062,"href":"https:\/\/apexbtic.icgeb.res.in\/btisnet\/wp-json\/wp\/v2\/pages\/257\/revisions\/1062"}],"wp:attachment":[{"href":"https:\/\/apexbtic.icgeb.res.in\/btisnet\/wp-json\/wp\/v2\/media?parent=257"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}